Electronic Body Maps Drive Standardization Across Top-10 Pharma

A top-10 pharmaceutical company sought to standardize the conduct of their diabetic polyneuropathy trials in preparation for future research initiatives. The primary focus was on modernizing their methodology by digitizing the paper-based “body map” forms. These forms are crucial for participants to indicate the severity and location of pain on their bodies.

Historically, these body map assessments were administered on paper, which led to potential inefficiencies and errors. The paper-based system was prone to issues such as misinterpretation of data, delays in processing, and difficulty in tracking and analyzing the information accurately.

The client’s objective was to transition from the traditional paper forms to a digital format, enabling a more efficient and reliable data collection process. They aimed to co-create and have full ownership of their digital body maps, ensuring they met the specific needs of their trials. By digitizing these assessments, the client hoped to simplify and streamline the process, making it more efficient for both current and future diabetic polyneuropathy trials. This initiative was expected to enhance data accuracy, reduce administrative burdens, and improve the overall participant experience.